Donna M Rennick

USPTO Granted Patents = 21 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 342(Granted Patents)

Location History:

Los Altos Hills, CA (US) (1987)
Los Altos, CA (US) (1991 - 2014)

Company Filing History:

Dnax Research Institute of Molecular and Cellular Biology, Inc.

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 1987-2014

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8691953 - Binding compounds for IL-27 (2014-04-08),

2. 8080392 - IL-D80 polynucleotides (2011-12-20),

3. 7906622 - IL-D80 polypeptides and IL-27 (2011-03-15),

4. 7883695 - IL-12P40 and IL-B30 polypeptide complex (2011-02-08),

5. 7579440 - Mammalian cytokines; related reagents (2009-08-25),

6. 7357924 - Uses of IL-174 for treating helminth infections (2008-04-15),

7. 7183382 - Mammalian genes; related reagents and methods (2007-02-27),

8. 7148330 - Binding compounds for IL-27 (2006-12-12),

9. 7090847 - Mammalian cytokines; related reagents and methods (2006-08-15),

10. 6676939 - Methods of modulating IL-174 response (2004-01-13),

11. 6395268 - Lymphotactin uses (2002-05-28),

12. 5955315 - Nucleic acids encoding human interleukin-4 (1999-09-21),

13. 5951973 - Use of interleukin-4 (IL-4) to treat rheumatoid arthritis (1999-09-14),

14. 5807996 - Fused polypeptides comprising interleukin-4 polypeptide fragments (1998-09-15),

15. 5730970 - Pharmaceutical compositions comprising human interleukin-4 (IL-4) (1998-03-24),

Title: The Innovative Contributions of Donna M. Rennick: A Leader in Cytokine Research

Introduction: Donna M. Rennick, an accomplished inventor residing in Los Altos, CA, has made significant strides in the field of molecular biology and immunology. With a total of 21 patents to her name, she has contributed to the advancement of our understanding of cytokines, particularly in relation to IL-27.

Latest Patents: Donna's recent innovations include patents related to binding compounds for IL-27 and the development of IL-D80 polynucleotides. These patents detail the purification of genes encoding cytokines, along with the creation of specific antibodies and nucleic acids. Furthermore, they encompass methods for utilizing these reagents in diagnostic kits, which can be essential tools in medical research and clinical applications.

Career Highlights: Throughout her career, Donna has held key positions in prestigious organizations that emphasize research and development in biotechnology. Notable companies include the Schering Corporation and Dnax Research Institute of Molecular and Cellular Biology, Inc., where she has played a pivotal role in advancing cytokine-related innovations.

Collaborations: Donna's work has also included collaboration with esteemed colleagues such as Frank D. Lee and Takashi Yokota. These partnerships have fostered a synergistic approach to research, enhancing the impact of her work in the scientific community.

Conclusion: Donna M. Rennick's contributions to cytokine research are commendable, characterized by her innovative patents and collaborative spirit. Her ongoing work continues to push the boundaries of molecular biology, solidifying her reputation as a leading inventor in her field.

This text is generated by artificial intelligence and may not be accurate.